Genome

Scientists Resolve Epilepsy-Causing Repeat Expansion with Sequel System

3 monthes ago   |   By Pacific Biosciences

Scientists in Japan report using the unique properties of SMRT Sequencing to detect a structural variant responsible for a hereditary form of epilepsy. The 4.6 kb intronic repeat insertion was found from low-coverage whole genome sequence data, leading the team to suggest that this approach could be useful for determining the genetic mechanisms behind many unexplained diseases.
“ Detecting a long insertion variant in SAMD12 by SMRT sequencing: implications of long-read whole-genome sequencing for repeat expansion diseases ” comes from lead author Takeshi Mizuguchi, senior author Satoko...
Read more ...

 


Search by Tags

   Genome      Paper      Environmental      Medicine      Health      Genetics      Genomics      Blog      Pathogenic variant      Repeat expansion disorder      Structural variation  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round

Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round

The race to bring CAR-T cell therapy to multiple myeloma, a persistent and deadly cancer of the bone marrow, continued on Monday with a fresh round of funding for Poseida... Read more ...

Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer

Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer

Merck's blockbuster immunotherapy has notched FDA approval for treating the most serious cases of kidney cancer. The FDA on Monday approved Merck drug pembrolizumab in... Read more ...

Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings

Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings

Imbed Biosciences, a developer of ultra-thin, silver-based wound dressing materials, will step up its sales and marketing efforts with the help of a fresh $2 million venture... Read more ...

A week in visuals: Missouri Life Sciences Week 2019

A week in visuals: Missouri Life Sciences Week 2019

Missouri Life Sciences Week 2019 wrapped up on Friday. It brought us a taste of science across our broad research community at Mizzou. From students presenting their hard work... Read more ...

SPECIAL REPORT: 2019 Blockchain Outlook - Reality Check

SPECIAL REPORT: 2019 Blockchain Outlook - Reality Check

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures... Read more ...

Censinet Takes Off With $7.8M To Track Cyber Risks in Healthcare

Censinet Takes Off With $7.8M To Track Cyber Risks in Healthcare

Censinet, a Boston startup helpings hospitals and other healthcare providers manage the cyber risk of their hundreds of third-party vendors, has launched its system and... Read more ...

Join Xconomy for Our 8th Annual Napa Summit, June 13-14

Join Xconomy for Our 8th Annual Napa Summit, June 13-14

Google. Amazon. Genentech. Those are some of the companies you'll hear from at this year's Napa Summit , the Xconomy Retreat on Technology, Jobs, and Growth. This is our most... Read more ...

ServiceNow Alum's Perspectium Adds $8M More for Integration Tools

ServiceNow Alum's Perspectium Adds $8M More for Integration Tools

ServiceNow, one of the most valuable software companies ever founded in San Diego, launched in 2003, before enterprise software-as-a-service became a topic of mainstream... Read more ...

Can We Afford to be Cured? A Conversation with ICER's Steve Pearson

Can We Afford to be Cured? A Conversation with ICER's Steve Pearson

New cell and gene therapies bring the possibility of cures once hardly imaginable. But the potential cures could also cost millions of dollars, like Novartis , the owner of the... Read more ...

Aptiv Expands Driverless Car Testing, Opens Chinese Mobility Center

Aptiv Expands Driverless Car Testing, Opens Chinese Mobility Center

Aptiv , a global automotive technology company, announced last week that it has opened a new innovation hub in China-the fastest growing front in the self-driving tech wars... Read more ...